Dual inhibitor design for HIV-1 reverse transcriptase and integrase enzymes: a molecular docking study

References

• Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., … Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 220(4599), 868–871. doi:10.1126/science.6189183
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., … Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. doi:10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Biovia, D. S. (2019). Discovery visualizer studio (Version v19.1.0.18287). San Diego, CA: Dassault Systèmes.
   Google Scholar
• Chen, D., Menche, G., Power, T. D., Sower, L., Peterson, J. W., & Schein, C. H. (2007). Accounting for ligand-bound metal ions in docking small molecules on adenylyl cyclase toxins. Proteins: Structure, Function, and Bioinformatics, 67(3), 593–605. doi:10.1002/prot.21249
   PubMed Web of Science ®Google Scholar
• De Luca, L., De Grazia, S., Ferro, S., Gitto, R., Christ, F., Debyser, Z., & Chimirri, A. (2011). HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation. European Journal of Medicinal Chemistry, 46(2), 756–764. doi:10.1016/j.ejmech.2010.12.012
   PubMed Web of Science ®Google Scholar
• Feltrin, L. (2015). KNIME an open source solution for predictive analytics in the geosciences. IEEE Geoscience and Remote Sensing Magazine, 3(4), 28. doi:10.1109/MGRS.2015.2496160
   Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., ... Fox, D. J. (2009). Gaussian 09 (Verion Revision E.01). Wallingford, CT.
   Google Scholar
• Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., … Popovic, M. (1983). Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science, 220(4599), 865–867. doi:10.1126/science.6601823
   PubMed Web of Science ®Google Scholar
• Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010). Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proceedings of the National Academy of Sciences of Sciences, 107(46), 20057–20062. doi:10.1073/pnas.1010246107
   PubMed Web of Science ®Google Scholar
• Hindmarsh, P., & Leis, J. (1999). Retroviral DNA integration. Microbiology and Molecular Biology Reviews, 63(4), 836–843.
   PubMed Web of Science ®Google Scholar
• Jacobomolina, A., & Arnold, E. (1991). Hiv reverse-transcriptase structure-function-relationships. Biochemistry, 30(26), 6351–6361. doi:10.1021/bi00240a001
   PubMed Web of Science ®Google Scholar
• Kawasuji, T., Fuji, M., Yoshinaga, T., Sato, A., Fujiwara, T., & Kiyama, R. (2006). A platform for designing HIV integrase inhibitors. Part 2: A two-metal binding model as a potential mechanism of HIV integrase inhibitors. Bioorganic & Medicinal Chemistry, 14(24), 8420–8429. doi:10.1016/j.bmc.2006.08.043
   PubMed Web of Science ®Google Scholar
• Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., … Bolton, E. E. (2019). PubChem 2019 update: Improved access to chemical data. Nucleic Acids Research, 47(D1), D1102–D1109. doi:10.1093/nar/gky1033
   PubMed Web of Science ®Google Scholar
• Kuroda, D. G., Bauman, J. D., Challa, J. R., Patel, D., Troxler, T., Das, K., … Hochstrasser, R. M. (2013). Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase. Nature Chemistry, 5(3), 174–181. doi:10.1038/nchem.1559
   PubMed Web of Science ®Google Scholar
• Marvin was used for drawing, d. a. c. c. s., substructures and reactions. (2017). (Version Marvin 17.24.0): ChemAxon. Retrieved from http://www.chemaxon.com
   Google Scholar
• Meden, A., Knez, D., Jukic, M., Brazzolotto, X., Grsic, M., Pislar, A., … Groselj, U. (2019). Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease. Chemical Communications, 55(26), 3765–3768. doi:10.1039/C9CC01330J
   PubMed Web of Science ®Google Scholar
• Moonsamy, S., & Soliman, M. E. S. (2014). Dual acting HIV inhibitors: Integrated rational in silico design strategy. Medicinal Chemistry Research, 23(2), 682–689. doi:10.1007/s00044-013-0670
   Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. doi:10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Pendri, A., Meanwell, N. A., Peese, K. M., & Walker, M. A. (2011). New first and second generation inhibitors of human immunodeficiency virus-1 integrase. Expert Opinion on Therapeutic Patents, 21(8), 1173–1189. doi:10.1517/13543776.2011.586631
   PubMed Web of Science ®Google Scholar
• Perryman, A. L., Forli, S., Morris, G. M., Burt, C., Cheng, Y., Palmer, M. J., … Olson, A. J. (2010). A dynamic model of HIV integrase inhibition and drug resistance. Journal of Molecular Biology, 397(2), 600–615. doi:10.1016/j.jmb.2010.01.033
   PubMed Web of Science ®Google Scholar
• Perryman, A. L., & McCammon, J. A. (2002). AutoDocking dinucleotides to the HIV-1 integrase core domain: Exploring possible binding sites for viral and genomic DNA. Journal of Medicinal Chemistry, 45(26), 5624–5627. doi:10.1021/jm025554m
   PubMed Web of Science ®Google Scholar
• Pierce, A. C., Rao, G., & Bemis, G. W. (2004). BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, P38, and HIV protease. Journal of Medicinal Chemistry, 47(11), 2768–2775. doi:10.1021/jm030543u
   PubMed Web of Science ®Google Scholar
• Poongavanam, V., Moorthy, N. S. H. N., & Kongsted, J. (2014). Dual mechanism of HIV-1 integrase and RNase H inhibition by diketo derivatives - A computational study. RSC Advances, 4(73), 38672–38681. doi:10.1039/C4RA05728G
   Web of Science ®Google Scholar
• Prasasty, V. D., Anthony Hutagalung, R., Grazzolie, K., & Ivan, F. X. (2018). Selective docking of promising retroviral integrase inhibitors towards prototype foamy virus integrase. Journal of Medicinal Plants Studies, 6(2), 265–272.
   Google Scholar
• Sander, T., Freyss, J., von Korff, M., & Rufener, C. (2015). DataWarrior: An open-source program for chemistry aware data visualization and analysis. Journal of Chemical Information and Modeling, 55(2), 460–473. doi:10.1021/ci500588j
   PubMed Web of Science ®Google Scholar
• Sarafianos, S. G., Marchand, B., Das, K., Himmel, D. M., Parniak, M. A., Hughes, S. H., & Arnold, E. (2009). Structure and function of HIV-1 reverse transcriptase: Molecular mechanisms of polymerization and inhibition. Journal of Molecular Biology, 385(3), 693–713. doi:10.1016/j.jmb.2008.10.071
   PubMed Web of Science ®Google Scholar
• Schames, J. R., Henchman, R. H., Siegel, J. S., Sotriffer, C. A., Ni, H. H., & McCammon, J. A. (2004). Discovery of a novel binding trench in HIV integrase. Journal of Medicinal Chemistry, 47(8), 1879–1881. doi:10.1021/jm0341913
   PubMed Web of Science ®Google Scholar
• Schrödinger. (2019). Schrödinger release 2019-3. New York, NY: Maestro, LLC.
   Google Scholar
• Sun, L., Gao, P., Dong, G., Zhang, X., Cheng, X., Ding, X., … Liu, X. (2018). 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase. European Journal of Medicinal Chemistry, 155, 714–724. doi:10.1016/j.ejmech.2018.06.036
   PubMed Web of Science ®Google Scholar
• Turner, B. G., & Summers, M. F. (1999). Structural biology of HIV. Journal of Molecular Biology, 285(1), 1–32. doi:10.1006/jmbi.1998.2354
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2019). UNAIDS data 2018. Retrieved from http://www.unaids.org/en/resources/documents/2018/unaids-data-2018
   Google Scholar
• Wang, Z., Bennett, E. M., Wilson, D. J., Salomon, C., & Vince, R. (2007). Rationally designed dual inhibitors of HIV reverse transcriptase and integrase. Journal of Medicinal Chemistry, 50(15), 3416–3419. doi:10.1021/jm070512p
   PubMed Web of Science ®Google Scholar
• Wolf, A., Zimmermann, M., & Hofmann-Apitius, M. (2007). Alternative to consensus scoring–A new approach toward the qualitative combination of docking algorithms. Journal of Chemical Information and Modeling, 47(3), 1036–1044. doi:10.1021/ci6004965
   PubMed Web of Science ®Google Scholar
• Yeni, P. (2006). Update on HAART in HIV. Journal of Hepatology, 44(1 Suppl), S100–S103. doi:10.1016/j.jhep.2005.11.021
   PubMedGoogle Scholar
• Zhang, D., Debnath, B., Yu, S., Sanchez, T. W., Christ, F., Liu, Y., … Zhao, G. (2014). Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase. Bioorganic & Medicinal Chemistry, 22(19), 5446–5453. doi:10.1016/j.bmc.2014.07.036
   PubMed Web of Science ®Google Scholar